QA

Troikaa mainly focuses on Novel Drug Delivery Systems (NDDS). The company firmly believes in providing superior therapeutic benefits by improvising the formulations through Innovative Technologies.
Six patents have been filed in various areas of drug delivery. To handle competition, Troikaa adopted various multifaceted strategies to help stand their ground in the competitive market. Another fact that helps us stand out is their high quality products.

Venus start each day by focussing on Innovation & Creativity. We make sure that best healthcare is provided to our patients worldwide.
From a humble beginning in 1991, now we are engaged & engrossed in discovering, developing and delivering innovative pharmaceuticals that help patients to alleviate sufferings.

Akums Drugs & Pharmaceuticals Limited; Haridwar, Uttaranchal (India) was established & formed in the year 2004 by Shri D. C. Jain, Shri Sanjeev Jain & Shri Sandeep Jain, the Promoter Directors, having over 30 years of experience in Pharmaceutical Manufacturing.

In 1994, when Smithkline Beecham tasked Medreich plc to source quality generic drugs, for its Africa operations, it came upon a little company that had world class quality parameters. This company was guided by the Beecham technical and regulatory protocols that it used in its own facility in UK. The little company, Medreich, has come a long way since then.

Nectar Lifesciences Ltd (NecLife) is a 200 million US$ integrated pharmaceutical organization, offering comprehensive range of Cephalosporin Active Pharmaceutical Ingredients and Finished Dosage Forms. The development and manufacture of quality intermediates, bulk actives have been critical to our success to become one of the largest manufacturers of cephalosporin range of products and delivering innovative and affordable products to domestic as well as international markets.

Surya Healthcare is a subsidiary of Surya Pharmaceuticals Limited with widespread domestic and international operations. The force behind Surya Healthcare is its parent company Surya Pharmaceuticals Limited. It is uniquely positioned in the Pharmaceutical trade known for its competencies in API, formulation and contract manufacturing across different therapeutic segments serving both domestic and international clients.

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.